| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.19 | 9e-06 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.094 | 0.04 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.086 | 0.09 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.069 | 0.2 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.053 | 0.3 |